Firms

Relativity Healthcare Partners

Healthcare investment group providing family-office and growth capital to emerging companies developing medicines, medical devices, health technology and healthcare services. Its executives combine clinical experience with investment evaluation, financial strategy and company-building support. The firm participated in Anodyne Nanotech’s 2026 Series A for a microneedle patch that delivers biologic medicines through the skin, and in OrphoMed’s 2017 financing for gastrointestinal drug development.

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Alfonso ChangManaging Director
Michael ChaoSenior Managing Director

Co-investing

Investments